M. Murris‐Espin

2.0k total citations
43 papers, 744 citations indexed

About

M. Murris‐Espin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, M. Murris‐Espin has authored 43 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in M. Murris‐Espin's work include Cystic Fibrosis Research Advances (19 papers), Tracheal and airway disorders (7 papers) and Pediatric health and respiratory diseases (5 papers). M. Murris‐Espin is often cited by papers focused on Cystic Fibrosis Research Advances (19 papers), Tracheal and airway disorders (7 papers) and Pediatric health and respiratory diseases (5 papers). M. Murris‐Espin collaborates with scholars based in France, United Kingdom and Germany. M. Murris‐Espin's co-authors include A. Didier, Pierre‐Régis Burgel, Laurent Mély, R. Nové-Josserand, É. Serrano, P Léophonte, D. Hubert, J. Rami, I. Durieu and Paulo Flores and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Biomechanics and European Respiratory Journal.

In The Last Decade

M. Murris‐Espin

38 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Murris‐Espin France 18 495 210 93 88 72 43 744
Jonathan Rutland Australia 17 744 1.5× 138 0.7× 100 1.1× 171 1.9× 60 0.8× 34 1.2k
T.J. Warke United Kingdom 10 438 0.9× 358 1.7× 51 0.5× 31 0.4× 48 0.7× 13 620
Michael Miligkos Greece 18 168 0.3× 307 1.5× 102 1.1× 121 1.4× 46 0.6× 39 954
Geovanny F. Pérez United States 17 342 0.7× 132 0.6× 234 2.5× 97 1.1× 27 0.4× 59 692
Benjamin B. Cable United States 16 202 0.4× 147 0.7× 47 0.5× 267 3.0× 20 0.3× 42 666
P Faurschou Denmark 16 693 1.4× 350 1.7× 49 0.5× 138 1.6× 49 0.7× 50 904
John Massie Australia 7 955 1.9× 108 0.5× 102 1.1× 92 1.0× 8 0.1× 9 1.1k
Cordula Koerner‐Rettberg Germany 14 399 0.8× 110 0.5× 132 1.4× 70 0.8× 20 0.3× 53 633
Ina Callebaut Belgium 15 124 0.3× 258 1.2× 40 0.4× 84 1.0× 262 3.6× 38 595
Miguel Mayo‐Yáñez Spain 12 191 0.4× 111 0.5× 29 0.3× 154 1.8× 29 0.4× 107 617

Countries citing papers authored by M. Murris‐Espin

Since Specialization
Citations

This map shows the geographic impact of M. Murris‐Espin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Murris‐Espin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Murris‐Espin more than expected).

Fields of papers citing papers by M. Murris‐Espin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Murris‐Espin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Murris‐Espin. The network helps show where M. Murris‐Espin may publish in the future.

Co-authorship network of co-authors of M. Murris‐Espin

This figure shows the co-authorship network connecting the top 25 collaborators of M. Murris‐Espin. A scholar is included among the top collaborators of M. Murris‐Espin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Murris‐Espin. M. Murris‐Espin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgel, Pierre‐Régis, Jean-Louis Paillasseur, I. Durieu, et al.. (2024). Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease. Annals of the American Thoracic Society. 21(7). 1053–1064. 18 indexed citations
2.
Hamidfar, Rébecca, M. Murris‐Espin, Sophie Jacques, et al.. (2023). Feasibility of home initiation of an airway clearance device (SIMEOX) by telecare in people with non-cystic fibrosis bronchiectasis: a pilot study. BMJ Open Respiratory Research. 10(1). e001722–e001722. 1 indexed citations
3.
Elborn, J.S., Francesco Blasi, Charles Haworth, et al.. (2022). Bronchiectasis and inhaled tobramycin: A literature review. Respiratory Medicine. 192. 106728–106728. 21 indexed citations
4.
Schlemmer, F., M. Murris‐Espin, Benoît Douvry, et al.. (2021). Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis: A survey of French pulmonologist's practices. Respiratory Medicine and Research. 80. 100859–100859. 1 indexed citations
5.
Burgel, Pierre‐Régis, À. Munck, I. Durieu, et al.. (2019). Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 201(2). 188–197. 92 indexed citations
6.
Plat, Gavin, et al.. (2018). Use of Ultrasonography for Lung Transplant Recipients on Postoperative Care. Journal of Ultrasound in Medicine. 38(4). 1101–1108. 4 indexed citations
7.
Anne-Archard, Dominique, et al.. (2016). Numerical and experimental investigation of mucociliary clearance breakdown in cystic fibrosis. Journal of Biomechanics. 53. 56–63. 35 indexed citations
8.
Nové-Josserand, R., S. Grard, Philippe Reix, et al.. (2016). Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Pediatric Pulmonology. 52(2). 190–197. 33 indexed citations
9.
Hubert, D., S. Bui, C. Marguet, et al.. (2016). Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR. Revue des Maladies Respiratoires. 33(8). 658–665. 4 indexed citations
10.
Murris‐Espin, M., et al.. (2016). Transition enfant-adulte au cours de la mucoviscidose. Archives de Pédiatrie. 23(12). 12S54–12S60. 3 indexed citations
11.
Bui, S., Julie Macey, Michaël Fayon, et al.. (2016). Nouvelles thérapeutiques ciblant le canal chlorure dans la mucoviscidose. Archives de Pédiatrie. 23(12). 12S47–12S53. 1 indexed citations
12.
Damy, Thibaud, Pierre‐Régis Burgel, Jean‐Louis Pépin, et al.. (2012). Pulmonary Acceleration Time to Optimize the Timing of Lung Transplant in Cystic Fibrosis. Pulmonary Circulation. 2(1). 75–83. 12 indexed citations
13.
Hubert, D., Sylvie Leroy, R. Nové-Josserand, et al.. (2009). Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis. Journal of Cystic Fibrosis. 8(5). 332–337. 50 indexed citations
14.
Fauroux, Brigitte, Pierre‐Régis Burgel, Pierre‐Yves Boëlle, et al.. (2008). Practice of Noninvasive Ventilation for Cystic Fibrosis: A Nationwide Survey in France. Respiratory Care. 53(11). 1482–1489. 25 indexed citations
15.
Percodani, J., et al.. (1999). Nasopharyngeal tuberculosis. The Journal of Laryngology & Otology. 113(10). 928–931. 25 indexed citations
16.
Murris‐Espin, M., et al.. (1998). Comparison of Efficacy and Safety of Cetirizine and Ebastine in Patients with Perennial Allergic Rhinitis. Annals of Allergy Asthma & Immunology. 80(5). 399–403. 26 indexed citations
17.
Léophonte, P, et al.. (1998). The place of antimicrobial chemotherapy in the treatment of adults with acute bronchitis: a double-blind placebo-controlled trial. Clinical Microbiology and Infection. 4(8). 436–441. 5 indexed citations
18.
Bachaud, Jean‐Marc, M. Murris‐Espin, C. Hermant, et al.. (1998). Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide schedule. European Journal of Clinical Pharmacology. 54(9-10). 677–683. 18 indexed citations
19.
Murris‐Espin, M., et al.. (1997). Metastatic pulmonary calcification after renal transplantation. European Respiratory Journal. 10(8). 1925–1927. 31 indexed citations
20.
Murris‐Espin, M., Éric Pinelli, Bernard Pipy, P Léophonte, & A. Didier. (1995). Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production. Allergy. 50(4). 334–339. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Rutland Breakdown of academic impact, for papers by T.J. Warke Breakdown of academic impact, for papers by Michael Miligkos Breakdown of academic impact, for papers by Geovanny F. Pérez Breakdown of academic impact, for papers by Benjamin B. Cable Breakdown of academic impact, for papers by P Faurschou Breakdown of academic impact, for papers by John Massie Breakdown of academic impact, for papers by Cordula Koerner‐Rettberg Breakdown of academic impact, for papers by Ina Callebaut Breakdown of academic impact, for papers by Miguel Mayo‐Yáñez
Rankless by CCL
2026